Advertisement

International Journal of Clinical Pharmacy

, Volume 36, Issue 1, pp 10–14 | Cite as

How do we better translate adherence research into improvements in patient care?

  • Adam La Caze
  • Gina GujralEmail author
  • William Neil Cottrell
Commentary

Introduction

Adherence to medicines in patients with chronic disease remains poor despite better recognition of the challenges of non-adherence and a concerted effort to address these challenges. Adherence research has progressed in recent years, both conceptually with the recent development of a taxonomy of adherence [1] and improved, if still flawed, evidence for the efficacy of some interventions [2]. However, a key challenge remains unmet: the translation of adherence research into clear advice for health professionals of effective strategies to better support the medication adherence of their patients. We outline some of the difficulties of improving the translation of adherence research into improvements in the care of individuals with chronic disease, and consider possible solutions. We have two suggestions for improving translation of adherence research: (1) better incorporation of what we know about adherence into interventions to improve adherence and (2) more sophisticated...

Notes

Acknowledgments

We like to thank Thi-Mi-Uyen Nguyen and Holly Ross for discussions relating to this commentary. Thanks also to two anonymous referees for helpful comments.

Funding

None.

Conflicts of interest

None.

References

  1. 1.
    Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.PubMedCrossRefGoogle Scholar
  2. 2.
    Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73(6):545–62.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inf Assoc. 2012;19(5):696–704.CrossRefGoogle Scholar
  4. 4.
    Nunes V, Neilson J, O’Flynn N, Calvert N, Kuntze S, Smithson H, et al. Clinical guidelines and evidence review for medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2009.Google Scholar
  5. 5.
    Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol. 2011;11:149.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane database Syst Rev 2008;(2):CD000011.Google Scholar
  7. 7.
    Johnson MO, Charlebois E, Morin SF, Remien RH, Chesney MA. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: the healthy living project randomized controlled study. J Acquir Immune Defic Syndr. 2007;46(5):574–80.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Johnson SS, Driskell MM, Johnson JL, Dyment SJ, Prochaska JO, Prochaska JM, et al. Transtheoretical model intervention for adherence to lipid-lowering drugs. Dis Manag. 2006;9(2):102–14.PubMedCrossRefGoogle Scholar
  9. 9.
    Ogedegbe G, Chaplin W, Schoenthaler A, Statman D, Berger D, Richardson T, et al. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens. 2008;21(10):1137–43.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Stacy JN, Schwartz SM, Ershoff D, Shreve MS. Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting. Popul Health Manag. 2009;12(5):241–54.PubMedCrossRefGoogle Scholar
  11. 11.
    Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoes AW, Leufkens HG. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003;9(5):404–11.PubMedCrossRefGoogle Scholar
  12. 12.
    Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE. Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy. 2000;20(4):410–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Cutrona SL, Choudhry NK, Fischer MA, Servi AD, Stedman M, Liberman JN, et al. Targeting cardiovascular medication adherence interventions. J Am Pharm Assoc (2003) 2012;52(3):381-97.Google Scholar
  14. 14.
    Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–95.PubMedCrossRefGoogle Scholar
  15. 15.
    World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.Google Scholar
  16. 16.
    Gearing RE, Townsend L, MacKenzie M, Charach A. Reconceptualizing medication adherence: six phases of dynamic adherence. Harv Rev Psychiatry. 2011;19(4):177–89.PubMedCrossRefGoogle Scholar
  17. 17.
    Gadkari AS, McHorney CA. Medication nonfulfillment rates and reasons: narrative systematic review. Curr Med Res Opin. 2010;26(3):683–705.PubMedCrossRefGoogle Scholar
  18. 18.
    Raebel MA, Carroll NM, Ellis JL, Schroeder EB, Bayliss EA. Importance of including early nonadherence in estimations of medication adherence. Ann Pharmacother. 2011;45(9):1053–60.PubMedCrossRefGoogle Scholar
  19. 19.
    Fischer MA, Choudhry NK, Brill G, Avorn J, Schneeweiss S, Hutchins D, et al. Trouble getting started: predictors of primary medication nonadherence. Am J Med. 2011;124(11):1081.e9–22.PubMedCrossRefGoogle Scholar
  20. 20.
    Cheetham TC, Niu F, Green K, Scott RD, Derose SF, Vansomphone SS, et al. Primary nonadherence to statin medications in a managed care organization. J Manag Care Pharm. 2013;19(5):367–73.PubMedGoogle Scholar
  21. 21.
    Reeve J, Hosking R, Allinson Y. Personal electronic health records: the start of a journey. Australian Prescr. 2013;36(3):70–3.Google Scholar
  22. 22.
    Nguyen TMU, LaCaze A, Cottrell WN. What are validated self-report adherence scales really measuring? A systematic review. Br J Clin Pharmacol 2013;In Press.Google Scholar
  23. 23.
    Menckeberg TT, Bouvy ML, Bracke M, Kaptein AA, Leufkens HG, Raaijmakers JAM, et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res. 2008;64(1):47–54.PubMedCrossRefGoogle Scholar
  24. 24.
    Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004;18(9):607–13.PubMedCrossRefGoogle Scholar
  25. 25.
    Schuz B, Marx C, Wurm S, Warner LM, Ziegelmann JP, Schwarzer R, et al. Medication beliefs predict medication adherence in older adults with multiple illnesses. J Psychosom Res. 2011;70(2):179–87.PubMedCrossRefGoogle Scholar
  26. 26.
    Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17(1):17–32.CrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2013

Authors and Affiliations

  • Adam La Caze
    • 1
  • Gina Gujral
    • 1
    Email author
  • William Neil Cottrell
    • 1
  1. 1.School of PharmacyThe University of QueenslandBrisbaneAustralia

Personalised recommendations